Previous reports have suggested that CKS1B was up-regulated in HCC, and its overexpression was associated with clinical invasiveness, which was regulated by multiple genes and molecular pathways (Okabe et al. 2001; Huang et al. 2010). Here, CKS1B is linked to hepatocellular carcinoma.